NEOG — NEOGEN CORP

—
Nasdaq · Health Care · Life Sciences Tools & Services · CIK 711377 ·
Last close
$10.90
Market Cap
$2.38B
52W High
$14.26
52W Low
$5.37
ADV30
3,452,170
Next earnings
2027-01-07

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Aug 2026 222,800,000 105,500,000 -1,800,000 -11,900,000 3,303,200,000 172,000,000 1,216,800,000
May 2026 225,300,000 107,800,000 3,100,000 -11,300,000 3,346,000,000 185,500,000 1,253,100,000
Feb 2026 211,200,000 99,000,000 -3,300,000 -17,000,000 3,359,000,000 159,900,000 1,256,600,000
Nov 2025 224,691,000 106,684,000 -5,377,000 -15,924,000 3,359,953,000 145,340,000 1,255,465,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$83,200,000
Investing CF
$70,500,000
Financing CF
$-99,400,000
CapEx
$-51,300,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.04
As of
2026-10-17

Balance + Analyst (yfinance extras)

Retained Earnings
$-544,300,000
Inventory
$144,300,000
Receivables
$146,800,000
ST Investments
$0
EBIT TTM
$50,134,000
Pretax Income TTM
$-8,956,000
Interest Exp TTM
$59,090,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$884,000,000
EBITDA
$109,000,000
Free Cash Flow
$38,936,000
Enterprise Value
$3,180,494,336
Total Cash
$172,000,000
Total Debt
$774,300,032
Shares Out
218,306,034
Trailing EPS
$-0.26
Book Value
$9.56
ROE
-2.7%
ROA
-0.1%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
May 2026 870,400,000 -21,600,000 -7,900,000 3,346,000,000 1,253,100,000 2,092,900,000 83,200,000
May 2025 894,700,000 -1,700,000 -1,092,000,000 3,443,800,000 1,372,600,000 2,071,200,000 58,200,000
May 2024 924,200,000 58,600,000 -9,400,000 4,548,833,000 1,404,691,000 3,144,142,000 35,300,000
May 2023 822,447,000 37,515,000 -22,870,000 4,554,432,000 1,420,215,000 3,134,217,000 41,028,000

TTM Snapshot

Revenues TTM
$870,400,000
NetIncome TTM
$-7,900,000
OpCashFlow TTM
—
Assets (Latest)
$3,359,000,000
Forward EPS
$0.40

Max Pain — expiry 2027-04-16 (volume-derived — Yahoo OI feed degraded)

max pain strike: $12.50 · spot: $11.08 · call volume: 5,005 · put volume: 5,040
Expected Move to 2027-04-16: ±$2.82 (25.45%) — implied range $8.26 – $13.90 · ATM straddle on $10.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
CLDX Celldex Therapeutics, Inc. $2.20B $28.04 —
NTLA Intellia Therapeutics, Inc. $1.37B $9.78 —
ABSI Absci Corp $1.31B $7.58 —
LNTH Lantheus Holdings, Inc. $6.66B $101.80 —
OABI OmniAb, Inc. $736.59M $5.05 —

News headlines (Yahoo Finance, 1h cache)

Neogen (NEOG) Up 6.7% Since Last Earnings Report: Can It Continue?
2026-11-05 15:30 · Yahoo
3 Reasons to sell NEOG and 1 stock to buy instead
2026-10-24 00:32 · Yahoo
NEOG vs. WFCF: Which Food Safety Stock Has Better Prospects?
2026-10-20 15:36 · Yahoo
NEOG Q3 Deep Dive: Commercial Execution, Innovation, and Operational Progress Shape Outlook
2026-10-19 15:44 · Yahoo
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve Cannabis
2026-10-12 11:55 · Yahoo
Neogen (NEOG) Received An FDA Warning Over Contaminated Veterinary Product
2026-10-08 16:19 · Yahoo
The 5 Most Interesting Analyst Questions From Neogen’s Q3 Earnings Call
2026-10-08 07:20 · Yahoo
Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031
2026-10-08 02:02 · Yahoo
Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day
2026-10-07 22:33 · Yahoo
Why Are Neogen (NEOG) Shares Soaring Today
2026-10-07 18:56 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.